Quantification of radiation-induced lung damage with CT scans: The possible benefit for radiogenomics

Authors

  • Dirk De Ruysscher Radiation Oncology, University Hospitals Leuven/KU Leuven, Leuven, Belgium; Department of Radiation Oncology (Maastro clinic), Maastricht University Medical Center, Maastricht, The Netherlands
  • Hoda Sharifi Department of Radiation Oncology (Maastro clinic), Maastricht University Medical Center, Maastricht, The Netherlands
  • Gilles Defraene Radiation Oncology, University Hospitals Leuven/KU Leuven, Leuven, Belgium
  • Sarah L. Kerns Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY, USA; Departments of Pathology and Genetics, Albert Einstein College of Medicine, Bronx, New York, NY, USA
  • Melissa Christiaens Radiation Oncology, University Hospitals Leuven/KU Leuven, Leuven, Belgium
  • Kim De Ruyck Department of Basic Medical Sciences, University Ghent, Ghent, Belgium
  • Stéphanie Peeters Radiation Oncology, University Hospitals Leuven/KU Leuven, Leuven, Belgium
  • Johan Vansteenkiste Respiratory Oncology, University Hospitals Leuven/KU Leuven, Leuven, Belgium
  • Robert Jeraj Departments of Medical Physics, Human Oncology, Radiology and Biomedical Engineering, University of Wisconsin, Madison, WI, USA
  • Frank Van Den Heuvel Radiation Oncology, University Hospitals Leuven/KU Leuven, Leuven, Belgium
  • Wouter van Elmpt Department of Radiation Oncology (Maastro clinic), Maastricht University Medical Center, Maastricht, The Netherlands

DOI:

https://doi.org/10.3109/0284186X.2013.813074

Abstract

Background. Radiation-induced lung damage (RILD) is an important problem. Although physical parameters such as the mean lung dose are used in clinical practice, they are not suited for individualised radiotherapy. Objective, quantitative measurements of RILD on a continuous instead of on an ordinal, semi-quantitative, semi-subjective scale, are needed. Methods. Hounsfield unit (HU) changes before versus three months post-radiotherapy were correlated per voxel with the radiotherapy dose in 95 lung cancer patients. Deformable registration was used to register pre- and post-CT scans and the density increase was quantified for various dose bins. The dose-response curve for increased HU was quantified using the slope of a linear regression (HU/Gy). The end-point for the toxicity analysis was dyspnoea ≥ grade 2. Results. Radiation dose was linearly correlated with the change in HU (mean R2 = 0.74 ± 0.28). No differences in HU/Gy between groups treated with stereotactic radiotherapy, conventional radiotherapy alone, sequential or concurrent chemo- radiotherapy were observed. In the whole patient group, 33/95 (34.7%) had dyspnoea ≥ G2. Of the 48 patients with a HU/Gy below the median, 16 (33.3%) developed dyspnoea ≥ G2, while in the 47 patients with a HU/Gy above the median, 17 (36.1%) had dyspnoea ≥ G2 (not significant). Individual patients showed a nearly 21-fold difference in radiosensitivity, with HU/Gy ranging from 0 to 10 HU/Gy. Conclusions. HU changes identify objectively the whole range of individual radiosensitivity on a continuous, quantitative scale. CT density changes may allow more robust and accurate radiogenomics studies.

Downloads

Download data is not yet available.

Downloads

Additional Files

Published

2013-10-01

How to Cite

De Ruysscher, D., Sharifi, H., Defraene, G., Kerns, S. L., Christiaens, M., De Ruyck, K., … van Elmpt, W. (2013). Quantification of radiation-induced lung damage with CT scans: The possible benefit for radiogenomics. Acta Oncologica, 52(7), 1405–1410. https://doi.org/10.3109/0284186X.2013.813074